DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
48 hedge funds and large institutions have $120M invested in DermTech, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 8 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
2% more funds holding
Funds holding: 47 → 48 (+1)
0% less capital invested
Capital invested by funds: $121M → $120M (-$572K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$11.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.97M |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$1.53M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$905K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$904K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$6.45M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.6M |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.57M |
| 4 |
PVI
Pura Vida Investments
New York
|
-$793K |
| 5 |
GIPM
G2 Investment Partners Management
New York
|
-$736K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GIPM
51
G2 Investment Partners Management
New York
| – | -$736K | -55,600 | Closed |
|
52
Jane Street
New York
| – | -$242K | -18,321 | Closed |
|
53
Renaissance Technologies
New York
| – | -$191K | -14,400 | Closed |
|
|
TAM
54
Tocqueville Asset Management
New York
| – | -$191K | -14,400 | Closed |
|
|
BFM
55
Boothbay Fund Management
New York
| – | -$159K | -12,000 | Closed |
|
56
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$232 | +20 | New |
|
DMTK Hedge Fund Activity: Q3 2020 in Review
48 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q3 2020, worth a combined $120M — down 0.47% from $121M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new DMTK positions and 8 closed out — a net gain of 1 holder — while 15 added to existing stakes and 10 trimmed.
The largest buyer was Farallon Capital Management, adding an estimated $11.9M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $6.45M sold.
- 48 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q3 2020, up from 47 in Q2 2020.
- Funds reported $120M of DermTech, Inc. Common Stock stock for Q3 2020, down 0.47% quarter-over-quarter.
- 9 funds opened new DermTech, Inc. Common Stock positions in Q3 2020 and 8 closed out, a net change of +1 holder.
- The largest DermTech, Inc. Common Stock buyer in Q3 2020 was Farallon Capital Management, an estimated $11.9M added.
- The largest DermTech, Inc. Common Stock seller in Q3 2020 was Perceptive Advisors, an estimated $6.45M sold.
Based on aggregated 13F filings for Q3 2020.